hotspot -WSS

hotspot

author：knowledge 2025-09-27 12:56:10 - browse：2

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke Thursday at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

As Cytokinetics faces pressure to sell itself to a large pharma company following positive late-stage results of its heart drug, CEO Robert Blum maintains that the biotech can launch the treatment — what would be its first approved medication — on its own.

Cytokinetics reported top-line results of its drug, aficamten, in obstructive hypertrophic cardiomyopathy, or oHCM, last December, sending its shares up on speculation the company would get acquired. Full Phase 3 results released this week further suggest the drug could be used more flexibly than a similar treatment sold by Bristol Myers Squibb, but investors have questioned whether the biotech has the resources and salesforce to compete with a large pharma company.

Blum, speaking Thursday at a talk during STAT’s Breakthrough Summit West, said that if prospective buyers approach the company, he will talk to them, but “at the same time, we’re pushing forward, as we always have, with the original intention to build a commercial business. And that’s not something new. That’s not something that’s a result of a failed M&A dialogue.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Iowa House, Senate pass 6

WSS

Novo Nordisk testing Wegovy against alcohol

As H5N1 spreads in cows, experts warn against drinking raw milk

Study: Pain burden is higher in Black NFL players than white ones

Novo Nordisk testing Wegovy against alcohol

Free medical tuition alone isn't enough to close gaps in primary care

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

As H5N1 spreads in cows, experts warn against drinking raw milk

New air purifier tech could be key to improving indoor air quality

Biden launches a new push to limit health care costs

Novavax promises a turnaround & Lilly roils the obesity market

Oak trusses raised to roof of fire

Affirmative action in medical school literally saved lives

Leqembi, other new Alzheimer’s drugs require better biomarkers

Anesthesiologist group: stop taking Ozempic before surgery

WuXi Biologics execs register to lobby as Congress comes for the company

leisure time

Petition to FDA: Get the lead out of consumer hair dyes

HCA discloses massive data breach affecting 11 million patients

Fertility clinic egg and embryo storage is a disaster

HCA discloses massive data breach affecting 11 million patients

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Supreme Court to hear if Covid misinformation is protected speech

focus

hotspot

leisure time

knowledge